Researchers at the Indian Institute of Technology (IIT), Madras, Tel Aviv University and Columbia University are studying a rare genetic brain disease called "GNB1 Encephalopathy" and trying to develop a drug to treat it effectively.
Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) presents scientific updates in oral and poster presentations selected for international conferences: theSociety
NeuroBo Pharmaceuticals (NRBO) and Enters Collaboration to License and Develop Portfolio of Dong-A s Cardio-Metabolic Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NeuroBo Pharmaceuticals, Inc and Dong-A ST Co Ltd Announce Strategic Collaboration to License and Develop Portfolio of Dong-A s Cardio-Metabolic Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.